1. EachPod

ReachMD CME - Podcast

ReachMD CME

 ReachMD

Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, cardiology, women's health and more. And our CME library is continuously growing, every quarter.

Health Science & Medicine Medicine
Update frequency
every day
Episodes
499
Years Active
2019 - 2025
Share to:
Setting the Stage of Real-World Data vs RCT

Setting the Stage of Real-World Data vs RCT

CME credits: 1.00
Valid until: 14-02-2026
Claim your CME credit at https://reachmd.com/programs/cme/setting-the-stage-of-real-world-data-vs-rct/32296/

The effective management of atrial fibr…

Fri 14 Feb 2025
Elevating Care for Patients With Severe Renal Disease in AAV

Elevating Care for Patients With Severe Renal Disease in AAV

CME credits: 0.75
Valid until: 14-02-2026
Claim your CME credit at https://reachmd.com/programs/cme/elevating-care-for-patients-with-severe-renal-disease-in-aav/32352/

Blood vessel inflammat…

Fri 14 Feb 2025
Understanding CNS Lesions in HER2+ Metastatic Breast Cancer

Understanding CNS Lesions in HER2+ Metastatic Breast Cancer

CME credits: 1.00
Valid until: 18-06-2026
Claim your CME credit at https://reachmd.com/programs/cme/understanding-cns-lesions-in-her2-metastatic-breast-cancer/29948/

The development and avai…

Thu 06 Feb 2025
Recent Updates in HER2-Targeted TKIs for Metastatic Breast Cancer

Recent Updates in HER2-Targeted TKIs for Metastatic Breast Cancer

CME credits: 1.00
Valid until: 18-06-2026
Claim your CME credit at https://reachmd.com/programs/cme/recent-updates-in-her2-targeted-tkis-for-metastatic-breast-cancer/29951/

The development a…

Thu 06 Feb 2025
HER2-Targeted TKI Combinations in Second-Line and Beyond MBC

HER2-Targeted TKI Combinations in Second-Line and Beyond MBC

CME credits: 1.00
Valid until: 18-06-2026
Claim your CME credit at https://reachmd.com/programs/cme/her2-targeted-tki-combinations-in-second-line-and-beyond-mbc/29945/

The development and av…

Thu 06 Feb 2025
Leveraging Clinical Data: HER2-Targeted ADCs in Second-Line and Beyond MBC

Leveraging Clinical Data: HER2-Targeted ADCs in Second-Line and Beyond MBC

CME credits: 1.00
Valid until: 18-06-2026
Claim your CME credit at https://reachmd.com/programs/cme/leveraging-clinical-data-her2-targeted-adcs-in-second-line-and-beyond-mbc/29946/

The devel…

Thu 06 Feb 2025
Systemic Management of Brain Metastases in HER2+ BC: Emerging Strategies and Treatment Approaches

Systemic Management of Brain Metastases in HER2+ BC: Emerging Strategies and Treatment Approaches

Thu 06 Feb 2025
Sequencing Strategies for Second-Line and Beyond Treatment of HER2+ MBC

Sequencing Strategies for Second-Line and Beyond Treatment of HER2+ MBC

CME credits: 1.00
Valid until: 18-06-2026
Claim your CME credit at https://reachmd.com/programs/cme/sequencing-strategies-for-second-line-and-beyond-treatment-of-her2-mbc/29947/

The developm…

Thu 06 Feb 2025
Emerging Data in HER2-Targeted ADCs for Metastatic Breast Cancer

Emerging Data in HER2-Targeted ADCs for Metastatic Breast Cancer

CME credits: 1.00
Valid until: 18-06-2026
Claim your CME credit at https://reachmd.com/programs/cme/emerging-data-in-her2-targeted-adcs-for-metastatic-breast-cancer/29952/

The development an…

Thu 06 Feb 2025
Applying Data Into Practice: Sequencing Strategies for HER2-Targeted Breast Cancer

Applying Data Into Practice: Sequencing Strategies for HER2-Targeted Breast Cancer

Thu 06 Feb 2025
Differentiating Agents in the Expanding HER2-Targeted Arsenal for Metastatic Breast Cancer

Differentiating Agents in the Expanding HER2-Targeted Arsenal for Metastatic Breast Cancer

Thu 06 Feb 2025
Optimizing Treatment Selection for HER2+ Breast Cancer Patients with Brain Metastases

Optimizing Treatment Selection for HER2+ Breast Cancer Patients with Brain Metastases

Thu 06 Feb 2025
Virtual Tumor Board: Maximizing the Potential of Immuno-Oncology in Early TNBC Through Personalized Care

Virtual Tumor Board: Maximizing the Potential of Immuno-Oncology in Early TNBC Through Personalized Care

Wed 05 Feb 2025
Beyond the Broadcast: Expert Insights on SGLT2 Inhibitors in Cardiometabolic Care

Beyond the Broadcast: Expert Insights on SGLT2 Inhibitors in Cardiometabolic Care

Tue 04 Feb 2025
The Safety of Sodium Oxybate in Treating Narcolepsy

The Safety of Sodium Oxybate in Treating Narcolepsy

CME credits: 0.50
Valid until: 31-01-2026
Claim your CME credit at https://reachmd.com/programs/cme/the-safety-of-sodium-oxybate-in-treating-narcolepsy/29457/

Sodium content and the disrupti…

Fri 31 Jan 2025
Key Patient Counseling Issues Surrounding FNAIT and Its Risk in Subsequent Pregnancies

Key Patient Counseling Issues Surrounding FNAIT and Its Risk in Subsequent Pregnancies

Fri 31 Jan 2025
Current Management Strategies for FNAIT

Current Management Strategies for FNAIT

CME credits: 1.00
Valid until: 31-01-2026
Claim your CME credit at https://reachmd.com/programs/cme/current-management-strategies-for-fnait/32278/

Fetal and neonatal alloimmune thrombocytope…

Fri 31 Jan 2025
Nipocalimab: An FcRn Inhibitor and Its Role in Treating HDFN

Nipocalimab: An FcRn Inhibitor and Its Role in Treating HDFN

CME credits: 1.00
Valid until: 31-01-2026
Claim your CME credit at https://reachmd.com/programs/cme/nipocalimab-an-fcrn-inhibitor-and-its-role-in-treating-hdfn/32282/

Fetal and neonatal allo…

Fri 31 Jan 2025
Classification/Suspecting a Diagnosis of FNAIT/NAIT

Classification/Suspecting a Diagnosis of FNAIT/NAIT

CME credits: 1.00
Valid until: 31-01-2026
Claim your CME credit at https://reachmd.com/programs/cme/classificationsuspecting-a-diagnosis-of-fnaitnait/32276/

Fetal and neonatal alloimmune thr…

Fri 31 Jan 2025
Screening for FNAIT: Anticipating HPA-1a Incompatibility

Screening for FNAIT: Anticipating HPA-1a Incompatibility

CME credits: 1.00
Valid until: 31-01-2026
Claim your CME credit at https://reachmd.com/programs/cme/screening-for-fnait-anticipating-hpa-1a-incompatibility/32280/

Fetal and neonatal alloimmu…

Fri 31 Jan 2025
Disclaimer: The podcast and artwork embedded on this page are the property of ReachMD. This content is not affiliated with or endorsed by eachpod.com.